ArticleFrontiers in medicine2024

Updated insights into adverse events associated with mepolizumab: a disproportionality analysis from the FDA adverse event reporting system database.

Shan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.